NKARs, such as NKG2D, DNAM-1 and NCRs NKp30, NKp44 and NKp46, interact with ligands frequently upregulated on tumor cells, thereby promoting NK cell activation, cytokine production and the elimination of tumor cells (1). The gene discussed is NCR2; the disease is neoplasm.